Analysis of sequence variations in the LDL receptor gene in Spain: General gene screening or search for specific alterations?

Clinical Chemistry

Volumn 52, Issue 6, 2006, Pages 1021-1025

  Blesa, Sebastian ^a   Garcia Garcia, Ana Barbara ^a   Martinez Hervas, Sergio ^a   Mansego, Maria Luisa ^a   Gonzalez Albert, Veronica ^a   Ascaso, Juan Francisco ^a   Carmena, Rafael ^a   Real, Jose Tomas ^a   Chaves, Felipe Javier ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; LOW DENSITY LIPOPROTEIN RECEPTOR;

ADULT; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; DIAGNOSTIC VALUE; DNA MICROARRAY; EXON; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; GENE; GENE FREQUENCY; GENE IDENTIFICATION; GENE REARRANGEMENT; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC PREDISPOSITION; GENETIC SCREENING; GENETIC VARIABILITY; HUMAN; INTRON; LDLR GENE; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PROMOTER REGION; SEQUENCE ANALYSIS; SPAIN;

APOLIPOPROTEINS B; GENETIC SCREENING; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; MUTATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECEPTORS, LDL; SEQUENCE ANALYSIS, DNA; SPAIN;

EID: 33646930026     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2006.067645     Document Type: Article

References (24)

1. Goldstein JL, Hobbs H, Brown MS. Familial Hypercholesterolemia. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Bases of Inherited Disease. New York: McGraw-Hill, 2001:2863-913.
2. Gould AL, Rossouw JE, Santanello NC, Heyse JF, Furberg CD. Cholesterol reduction yields clinical benefit: impact on statins trials. Circulation 1998;97:946-52.
3. Villeger L, Abifadel M, Allard D, Rabes JP, Thiart R, Kotze MJ, et al. The UMD-LDLR database: additions to the software and 490 new entries to the database. Hum Mutat 2002;20:81-7.
4. Muller PY, Miserez AR. Large heterogeneity of mutations in the gene encoding the low-density lipoprotein receptor in subjects with familial hypercholesterolaemia. Atheroscler Suppl 2004;5:1-5.
5. Dedoussis GV, Schmidt H, Genschel J. LDL-receptor mutations in Europe. Hum Mutat 2004;24:443-59.
6. Soria LF, Ludwig EH, Clarke HRG, Vega GL, Grundy SM, McCarthy BJ. Association between a specific apoB mutation and familial defective apoB100. Proc Natl Acad Sci U S A 1989;86:587-91.
7. Gaffney D, Reid JM, Cameron IM, Vass K, Caslake M, Sheperd J, et al. Independent mutations at codon 3500 of the apolipoprotein B gene are associated with hyperlipidaemia. Arterioscler Thromb Vasc Biol 1995;15:1025-9.
8. Nissen H, Hansen PS, Faergeman O, Horder M. Mutation screening of the codon 3500of the apoB gene by denaturing gradient-gel electrophoresis. Clin Chem 1995;41:419-23.
9. Maxwell KN, Breslow JL. Proprotein convertase subtilisin kexin 9: the third locus implicated in autosomal dominant hypercholesterolemia. Curr Opin Lipidol 2005;16:167-72.
10. Ejarque I, Real JT, Chaves FJ, Blesa S, Gonzalez V, Milian E et al. Clinical and biochemical characteristics of familial ligand-defective apo B-100 in a South European population. Med Clin 2004;123:456-9.
11. Fouchier SW, Defesche JC, Kastelein JJ, Sijbrands EJ. Familial defective apolipoprotein B versus familial hypercholesterolemia: an assessment of risk. Semin Vasc Med 2004;4:259-64.
12. Real JT, Chaves FJ, Civera M, Garcia-Garcia AB, Ascaso JF, Armengod ME, et al. Influence of FH Valencia 1 and 2 mutations of the LDL receptor gene on the response to simvastatin in subjects with molecularly defined heterozygous familial hypercholesterolemia in Spain. Med Clin 2001;116:81-5.
13. Chaves FJ, Real JT, Garcia-Garcia AB, Puig O, Ordovas JM, Ascaso JF, et al. Large rearrangements of the LDL receptor gene and lipid profile in a FH Spanish population. Eur J Clin Invest 2001;31:309-17.
14. Chaves FJ, Real JT, Garcia-Garcia AB, Civera M, Armengod ME, Ascaso JF, et al. Genetic diagnosis of familial hypercholesterolemia in a South European outbreed population: influence of low-density lipoprotein (LDL) receptor gene mutations on treatment response to simvastatin in total, LDL, and high-density lipoprotein cholesterol. J Clin Endocrinol Metab 2001;86:4926-32.
15. Choumerianou DM, Dedoussis GV. Familial hypercholesterolemia and response to statin therapy according to LDLR genetic background. Clin Chem Lab Med 2005;43:793-801.
16. Garcia-Garcia AB, Real JT, Puig O, Cebolla E, Marin-Garcia P, Martinez Ferrandis JI, et al. Molecular genetics of familial hypercholesterolemia in Spain: ten novel LDLR mutations and population analysis. Hum Mutat 2001;18:458-9.
17. Mozas P, Castillo S, Tejedor D, Reyes G, Alonso R, Franco M, et al. Molecular characterization of familial hypercholesterolemia in Spain: identification of 39 novel and 77 recurrent mutations in LDLR. Hum Mutat 2004:24-187.
18. Pocovi M, Civeira F, Alonso R, Mata P. Familial hypercholesterolemia in Spain: case-finding program, clinical and genetic aspects. Semin Vasc Med 2004;4:67-74.
19. Tejedor D, Castillo S, Mozas P, Jimenez E, Lopez M, Tejedor MT, et al., Spanish FH Group. Reliable low-density DNA array based on allele-specific probes for detection of 118 mutations causing familial hypercholesterolemia. Clin Chem 2005;51:1137-44.
20. Tilzer L, Thomas S, Moreno RF. Use of silica gel polymer for DNA extraction with organic solvents. Anal Biochem 1989;183:13-5.
21. Heath KE, Day IN, Humphries SE. Universal primer quantitative fluorescent multiplex (UPQFM) PCR: a method to detect major and minor rearrangements of the low density lipoprotein receptor gene. J Med Genet 2000;37:272-80.
22. Garcia-Garcia AB, Blesa S, Martinez-Hervas S, Mansego ML, Gonzalez-Albert V, Ascaso JF, et al. Semiquantitative multiplex PCR: a useful tool for large rearrangement screening and characterization. Hum Mutat 2006; (in press).
23. Ekstrom U, Abrahamson M, Sveger T, Sun XM, Soutar AK, Nilsson-Ehle P. Expression of an LDL receptor allele with two different mutations (E256K and I402T). Mol Pathol 2000;53:31-6.
24. Whittall RA, Matheus S, Cranston T, Miller GJ, Humphries SE. The intron 14 2140+5G>A variant in the low density lipoprotein receptor gene has no effect on plasma cholesterol levels. J Med Genet 2002;39:e57.